SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000895421-03-000035
Filing Date
2003-02-13
Accepted
2003-02-13 15:34:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT - ASSET MGT - MS npspharmaceuticals1.txt SC 13G/A 10056
  Complete submission text file 0000895421-03-000035.txt   12214
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46256 | Film No.: 03559371
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1221 SIXTH AVENUE 5TH FLOOR NEW YORK NY 10020
Business Address 1585 BROADWAY NEW YORK NY 10036 2127614000
MORGAN STANLEY (Filed by) CIK: 0000895421 (see all company filings)

IRS No.: 363145972 | State of Incorp.: DE | Fiscal Year End: 1130
SIC: 6199 Finance Services